Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Persistence Evaluation and Response Study for Immunotherapy Safety Tracking of Participants Who Receive an AvenCell CAR-T Cell Therapy

NCT07474051 is registered in ClinicalTrials.gov with AvenCell Therapeutics, Inc. as lead sponsor.

NCT NCT07474051
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07474051 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Persistence Evaluation and Response Study for Immunotherapy Safety Tracking of Participants Who Receive an AvenCell CAR-T Cell Therapy
Lead sponsor
AvenCell Therapeutics, Inc.
Phase
Observational
Overall status
Enrolling by invitation
Start date
January 29, 2026
Completion date
January 30, 2041
Enrollment
178 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

aml (acute myelogenous leukemia), b-cell lymphoma, chronic lymphocytic leukemia, hematologic malignancy, prostate cancer